Geneos Wealth Management’s FT Vest US Equity Enhance & Moderate Buffer ETF March XMAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.2K Hold
475
﹤0.01% 1781
2025
Q4
$19K Hold
475
﹤0.01% 1739
2025
Q3
$18.6K Hold
475
﹤0.01% 1743
2025
Q2
$18.2K Sell
475
-475
-50% -$17.6K ﹤0.01% 2073
2025
Q1
$34.9K Buy
950
+475
+100% +$17.4K ﹤0.01% 2094
2024
Q4
$17.2K Buy
+475
New +$17K ﹤0.01% 1804

Other funds holding XMAR

Geneos Wealth Management's XMAR Position: Q1 2026 in Review

Geneos Wealth Management held its FT Vest US Equity Enhance & Moderate Buffer ETF March (XMAR) position steady in Q1 2026 at 475 shares worth $19.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1781.

Geneos Wealth Management first reported a position in XMAR in Q4 2024 and has held it in 6 quarters since. The position peaked at $34.9K in Q1 2025. 69 funds tracked by Wall St. Rank hold XMAR as of Q1 2026.

  • Geneos Wealth Management held 475 shares of FT Vest US Equity Enhance & Moderate Buffer ETF March worth $19.2K as of Q1 2026.
  • Geneos Wealth Management left its FT Vest US Equity Enhance & Moderate Buffer ETF March share count unchanged in Q1 2026.
  • FT Vest US Equity Enhance & Moderate Buffer ETF March made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #1781 holding.
  • Geneos Wealth Management first reported a position in FT Vest US Equity Enhance & Moderate Buffer ETF March in Q4 2024 and has held it in 6 quarters since.
  • Geneos Wealth Management's FT Vest US Equity Enhance & Moderate Buffer ETF March position peaked at $34.9K in Q1 2025.
  • 69 funds tracked by Wall St. Rank held FT Vest US Equity Enhance & Moderate Buffer ETF March as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.